在达到指导方针推的阿米卡辛水平Mycobacterium avium复杂肺病的挑战
Takuya Akutsu1, Kazuya Tone1, Airi Hasegawa1
1Department of Respiratory Medicine, The Jikei University School of Medicine Kashiwa Hospital, 163-1 Kashiwashita, Kashiwa, Chiba 277-8567 Japan.
概括
这项研究发现,大多数患有耐火性Mycobacterium avium复杂性肺病的患者没有达到推的阿米卡辛峰值度. 需要进一步的研究来确认有效治疗的阿米卡辛水平.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐火性Mycobacterium avium复杂性肺病 (MAC-PD) 通常需要除了宏化物外,还需要氨基糖化物.
- 目前的指导方针建议针对静脉注射阿米卡辛 (AMK) 血清度达到65-80微克/毫升,每周三次给药.
- 在临床实践中实现这些目标AMK度的可行性是不确定的.
研究的目的:
- 评估在耐火性MAC-PD患者中达到指南推的阿米卡辛 (AMK) 峰值血清度.
- 评估AMK度与患者群体中治疗效果之间的关系.
主要方法:
- 从2018年到2022年,对9名耐火性MAC-PD患者进行了回顾性分析,这些患者每周接受三次AMK治疗,并服用≥2种口服药物 (包括宏类药物).
- 对AMK峰值血清度和临床疗效的评估.
- 平均AMK剂量为每天700毫克 (15.8毫克/公斤/天) 平均6个月.
主要成果:
- 获得的AMK峰值度中位数为47.1μg/mL,明显低于推的65-80μg/mL.
- 只有一个患者达到目标AMK度.
- 一个趋势表明,在临床有效的患者中,AMK度更高,尽管有一名患者经历了听力损失,需要停止AMK治疗.
结论:
- 在这项初步研究中,大多数耐火性MAC-PD患者没有达到指导方针建议的AMK峰值度.
- 小样本规模和回顾性设计限制了对AMK度与结果关系的最终结论.
- 未来的随机对照试验是必要的,以确定最佳的AMK度,以确保有效性和安全性.
更多相关视频
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
26.0K
11:28A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
28.9K
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
47
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
47
01:11Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54